6th Systemic Sclerosis World Congress

The 6th Systemic Sclerosis World Congress will provide an exciting and up to date scientific programme. The combination of hands-on workshops, lectures, oral presentations and satellite sessions will provide an eclectic mix of experiences that will be put at disposal for all attendees. We welcome you to join us in Prague in 2020 for a stimulating experience in the world of scleroderma

Prague, Czech Republic – March 5-7, 2020

6th Systemic Sclerosis World Congress

UPDATE April 2020

We are sorry to report that the World Scleroderma Congress will not be taking place in Prague in July given the continued uncertainty surrounding Covid-19 and neither are there any plans to postpone until later in the year.

We will keep you updated in any news that might come.

Patient Congress Progamme
Patient congress will take place at the first floor of the Prague Congress Center.
Simultaneous translation in Czech, Hungarian, German and Spanish is provided in Panorama Room on Friday, March 6 and Saturday, March 7.

Congress registration is now open.

Read the Announcement by FESCA of 6th World Scleroderma Patient Congress to learn more →

The first 5 congresses in Florence 2010, Madrid 2012, Rome 2014, Lisbon 2016 and Bordeaux 2018 were a significant successes. These congresses have contributed to the knowledge about scleroderma all over the world. Colleagues from different specialties, junior trainees, health professionals and patients have gathered together and they have profited by challenging programmes including clinical experience, interactive sessions and basic science. Along with the medical component of the congress, the patient program has grown with increasing attendance and extended lectures subjects.

The Steering Committee of the 6th Systemic Sclerosis World Congress believe that the 6th World Scleroderma Congress will provide an exciting and up to date scientific programme. Stay tuned for more information!

Scleroderma research

Scleroderma researchFESCA, Federation of European Scleroderma Associations aisbl, encourages and undertake surveys, research projects and clinical trials related to the systemic sclerosis disease, and the publication of the results of any such research.

FESCA is always looking for better therapies. This is why we are partners with many different pharma companies. Pay our Scleroderma projects section a visit, and learn more about scleroderma research projects we're involved in.

Share This